Adiponectin, adiponectin receptors, and epigenetic regulation of adipogenesis

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 76, Issue , 2011, Pages 257-265

  Kadowaki, T ^a   Yamauchi, T ^a   Waki, H ^a   Iwabu, M ^a   Okada Iwabu, M ^a   Nakamura, M ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; CCAAT ENHANCER BINDING PROTEIN; DNA BINDING PROTEIN; MITOCHONDRIAL TRANSCRIPTION FACTOR A; NUCLEAR RESPIRATORY FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SIRTUIN 1; THIOBARBITURIC ACID REACTIVE SUBSTANCE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR ALPHA;

ADIPOGENESIS; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL MATURATION; CHROMATIN STRUCTURE; DNA REPLICATION ORIGIN; DNA SEQUENCE; DOWN REGULATION; EPIGENETICS; FAMILY HISTORY; FATTY ACID OXIDATION; GENE EXPRESSION; GENOTYPE; GLUCONEOGENESIS; GLUCOSE METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MITOCHONDRIAL GENE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; UPREGULATION; 3T3 CELL LINE; ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL STRUCTURE; CHROMATIN; GENETIC REGULATION; MITOCHONDRIAL BIOGENESIS; MITOCHONDRION; MOLECULAR DYNAMICS; MOUSE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADIPOGENESIS; ADIPONECTIN; ANIMALS; BASE SEQUENCE; EPIGENESIS, GENETIC; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEOTIDE MOTIFS; RECEPTORS, ADIPONECTIN;

EID: 84865493096     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2012.76.010587     Document Type: Article

References (33)

1. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. 2001. The adipocytesecreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953.
2. Bryne JC, Valen E, Tang MH, Marstrand T, Winther O, da Piedade I, Krogh A, Lenhard B, Sandelin A. 2008. JASPAR, the open access database of transcription factor-binding profiles: New content and tools in the 2008 update. Nucleic Acids Res 36: D102-D106.
3. Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J. 2009. AMPK regulates energy expenditure by modulating NAD{thorn} metabolism and SIRT1 activity. Nature 458: 1056-1060.
4. Cantó C, Jiang LQ, Deshmukh AS, Mataki C, Coste A, Lagouge M, Zierath JR, Auxwerx J. 2010. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 11: 213-219.
5. Giresi PG, Kim J, McDaniell RM, Iyer VR, Lieb JD. 2007. FAIRE (formaldehyde-assisted isolation of regulatory elements) isolates active regulatory elements from human chromatin. Genome Res 17: 877-885.
6. Gupta RK, Arany Z, Seale P, Mepani RJ, Ye L, Conroe HM, Roby YA, Kulaga H, Reed RR, Spiegelman BM. 2010. Transcriptional control of preadipocyte determination by Zfp423. Nature 464: 619-623.
7. Handschin C, Spiegelman BM. 2008. The role of exercise and PGC1a in inflammation and chronic disease. Nature 454: 463-469.
8. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, et al. 2009. Histone modifications at human enhancers reflect global cell type-specific gene expression. Nature 459: 108-112.
9. Hu E, Liang P, Spiegelman BM. 1996. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271: 10697-10703.
10. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M, et al. 2010. Adiponectin and AdipoR1 regulate PGC1a and mitochondria by Ca2{thorn} andAMPK/SIRT1. Nature 464: 1313-1319.
11. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. 2006. Adiponectin and adiponectin receptors in insulin resistance, diabetes and metabolic syndrome-Adiponectin hypothesis. J Clin Invest 116: 1784-1792.
12. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. 1992. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771-774.
13. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, et al. 2002. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277: 25863-25866.
14. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. 1996. cDNA cloning and expression of a novel adipose specific collagenlike factor, apM1 (adiPose most abundant gene transcript 1). Biochem Biophys Res Commun 221: 286-289.
15. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, RidderstraÅle M, Laurila E, et al. 2003. PGC-1a-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273.
16. Mootha VK, Handschin C, Arlow D, Xie X, St Pierre J, Sihag S, Yang W, Altshuler D, Puigserver P, Patterson N, et al. 2004. Erra and Gabpa/b specify PGC-1a-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci 101: 6570-6575.
17. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. 1996. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 120: 803-812.
18. Nielsen R, Pedersen TA, Hagenbeek D, Moulos P, Siersbæk R, Megens E, Denissov S, Børgesen M, Francoijs KJ, Mandrup S, et al. 2008. Genome-wide profiling of PPARg:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev 22: 2953-2967.
19. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, et al. 2003. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci 100: 8466-8471.
20. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. 2004. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. New Engl J Med 350: 664-671.
21. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270: 26746-26749.
22. Schmidt SF, Jørgensen M, Chen Y, Nielsen R, Sandelin A, Mandrup S. 2011. Cross species comparison of C/EBPa and PPARg profiles in mouse and human adipocytes reveals interdependent retention of binding sites. BMC Genomics 12: 152.
23. Siersbæk R, Nielsen R, John S, Sung MH, Baek S, Loft A, Hager GL, Mandrup S. 2011. Extensive chromatin remodelling and establishment of transcription factor "hotspots" during early adipogenesis. EMBO J 30: 1459-1472.
24. Tontonoz P, Spiegelman BM. 2008. Fat and beyond: The diverse biology of PPARg. Annu Rev Biochem 77: 289-312.
25. Wakabayashi K, Okamura M, Tsutsumi S, Nishikawa NS, Tanaka T, Sakakibara I, Kitakami J, Ihara S, Hashimoto Y, Hamakubo T, et al. 2009. The peroxisome proliferator-activated receptor g/retinoid X receptor a heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop. Mol Cell Biol 29: 3544-3555.
26. Waki H, Nakamura M, Yamauchi T, Wakabayashi K, Yu J, Hirose-Yotsuya L, Take K, Sun W, Iwabu M, Okada-Iwabu M, et al. 2011. Global mapping of cell type-specific open chromatin by FAIRE-seq reveals the regulatory role of the NFI family in adipocyte differentiation. PLoS Genet 7: e1002311.
27. Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V, Meinhardt T, Prüss M, Reuter I, Schacherer F. 2000. TRANSFAC: An integrated system for gene expression regulation. Nucleic Acids Res 28: 316-319.
28. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, et al. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115-124.
29. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946.
30. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, et al. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295.
31. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Matsui J, Eto K, et al. 2003a. Globular adiponectin protected ob/ob mice from diabetes and apoE deficient mice from atherosclerosis. J Biol Chem 278: 2461-2468.
32. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, et al. 2003b. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769.
33. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M, Okada-Iwabu M, Kawamoto S, Kubota N, Kubota T, 2007. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13: 332-339.